RxSight, Inc.
RXST
$12.62
-$0.47-3.59%
NASDAQ
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Net Income | 16.71% | -43.91% | -37.93% | 6.31% | -4.26% |
| Total Depreciation and Amortization | 10.05% | -1.15% | 50.10% | -54.16% | 39.15% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -21.15% | 59.95% | 1.19% | 18.69% | -2.62% |
| Change in Net Operating Assets | 272.26% | 83.68% | -73.89% | -291.32% | 165.34% |
| Cash from Operations | 72.87% | 50.45% | -107.32% | -755.38% | 116.14% |
| Capital Expenditure | 62.20% | -167.30% | 32.11% | 23.21% | 27.58% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -152.03% | -24.46% | 888.92% | 126.57% | 92.85% |
| Cash from Investing | -161.45% | -29.74% | 1,479.92% | 114.25% | 91.99% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -533.33% | 76.92% | -8.33% | -9.09% | 0.00% |
| Issuance of Common Stock | -93.67% | 197.13% | -76.71% | -22.09% | -96.57% |
| Repurchase of Common Stock | -- | 100.00% | -- | 100.00% | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | 100.00% | 31.95% |
| Cash from Financing | -125.67% | 380.95% | -124.70% | 238.95% | -99.21% |
| Foreign Exchange rate Adjustments | -114.29% | 133.33% | 150.00% | -271.43% | 800.00% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -186.79% | 9.39% | 46,958.33% | 100.31% | 5.79% |